Teladoc Health (NYSE:TDOC) Given New $50.00 Price Target at Canaccord Genuity Group

Teladoc Health (NYSE:TDOCGet Rating) had its price target dropped by stock analysts at Canaccord Genuity Group from $112.00 to $50.00 in a research note issued on Thursday, The Fly reports. Canaccord Genuity Group’s target price would indicate a potential downside of 10.70% from the stock’s current price.

TDOC has been the subject of several other reports. Stifel Nicolaus reduced their target price on Teladoc Health from $83.00 to $74.00 and set a “hold” rating for the company in a research report on Wednesday, February 23rd. Bank of America cut their target price on Teladoc Health from $80.00 to $75.00 and set a “neutral” rating for the company in a research report on Wednesday, February 23rd. Argus upgraded Teladoc Health from a “hold” rating to a “buy” rating and set a $95.00 price target on the stock in a research report on Thursday, March 3rd. Evercore ISI cut their price objective on Teladoc Health from $90.00 to $70.00 and set an “inline” rating for the company in a report on Wednesday, February 23rd. Finally, William Blair lowered shares of Teladoc Health from an “outperform” rating to a “market perform” rating in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, sixteen have given a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Teladoc Health presently has a consensus rating of “Hold” and a consensus target price of $98.07.

Shares of TDOC opened at $55.99 on Thursday. The company has a market capitalization of $9.02 billion, a PE ratio of -20.21 and a beta of 0.43. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.70 and a quick ratio of 3.48. Teladoc Health has a one year low of $50.08 and a one year high of $189.65. The company’s fifty day moving average price is $65.99 and its 200 day moving average price is $90.30.

Teladoc Health (NYSE:TDOCGet Rating) last issued its quarterly earnings results on Wednesday, April 27th. The health services provider reported ($41.58) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.58) by ($41.00). Teladoc Health had a negative return on equity of 1.31% and a negative net margin of 21.09%. During the same period in the prior year, the company earned $0.13 earnings per share. Analysts anticipate that Teladoc Health will post -1.55 earnings per share for the current year.

In other Teladoc Health news, SVP Andrew Turitz sold 1,754 shares of the firm’s stock in a transaction on Thursday, March 3rd. The shares were sold at an average price of $70.24, for a total value of $123,200.96. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Adam C. Vandervoort sold 3,513 shares of the firm’s stock in a transaction on Thursday, March 3rd. The shares were sold at an average price of $70.24, for a total value of $246,753.12. The disclosure for this sale can be found here. Insiders have sold 14,842 shares of company stock valued at $1,042,502 in the last ninety days. Insiders own 6.47% of the company’s stock.

A number of hedge funds have recently modified their holdings of TDOC. City State Bank bought a new stake in shares of Teladoc Health during the 4th quarter valued at about $27,000. Liberty Wealth Management LLC lifted its position in Teladoc Health by 450.0% in the third quarter. Liberty Wealth Management LLC now owns 209 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 171 shares during the last quarter. Future Financial Wealth Managment LLC bought a new stake in Teladoc Health in the 4th quarter worth $29,000. CarsonAllaria Wealth Management Ltd. purchased a new stake in shares of Teladoc Health during the fourth quarter worth about $30,000. Finally, Marshall Wace North America L.P. purchased a new position in Teladoc Health during the 1st quarter valued at about $35,000. 86.68% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile (Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Read More

The Fly logo

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.